Monday, April 24, 2017 8:59:21 PM
PTI has 85 million in cash and a collaboration with Astellas for UPR Modulators worth up to $400 million in milestone payments, CF pipeline with PTI 428 and triple combination could be worth a fortune with good clinical results. MC is ridiculously low at this price IMHO.
The results of PTI 428 WITH 8 CF patients are due this quarter. If the results are good then the stock will sail. Also, good results will probably lead to TDN endorsement which will cause a bigger bounce. Results could be released any time in the 2Q.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM